Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma (TMI-ASCT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2010 by Ottawa Hospital Research Institute
Sponsor:
Information provided by:
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00800059
First received: November 27, 2008
Last updated: March 1, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2015
  Estimated Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)